Evidence map›Paper›PMID 34969825›Full record

ReviewGenes & development2022

The transcription factor activity gradient (TAG) model: contemplating a contact-independent mechanism for enhancer-promoter communication.

Jonathan P Karr, John J Ferrie, Robert Tjian, Xavier Darzacq

Abstract readReview
In one paragraph

Review in Genes & development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Article
  2. Current Challenges of Transcription Compartmentalization Research.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. SMARCD1 and Its Functional Relevance in SWI/SNF and Cancer.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. What makes genes burst.Trends in cell biology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  19. Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan P KarrUniversity of California at Berkeley, Berkeley, California 94720, USA.
John J FerrieUniversity of California at Berkeley, Berkeley, California 94720, USA.
Robert TjianUniversity of California at Berkeley, Berkeley, California 94720, USA.ORCID 0000-0003-0539-8217
Xavier DarzacqUniversity of California at Berkeley, Berkeley, California 94720, USA.ORCID 0000-0003-2537-8395

Funding

THE MOLECULAR BASIS OF CELL FUNCTIONT32GM007232 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BILDER, DAVID, UNAL, ELCIN · 1985 to 2022
$36.4M
Project 2: Evaluating the dynamic protein-protein interactions mediated by LCDs within EWS/FLI and its partners in living cells via single molecule imagingU54CA231641 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI LESSNICK, STEPHEN L. · 2018 to 2018
$6.2M
Howard Hughes Medical InstituteNCI NIH HHS U54 CA231641NIGMS NIH HHS T32 GM007232
6 · The paper itself

Abstract

How distal

Indexed as

Enhancer Elements, GeneticTranscription, GeneticGene Expression RegulationPromoter Regions, GeneticTranscription FactorsTranscription Factors3D genomecoactivatorenhancergene regulationp300transcription

Identifiers

PMID34969825
PMCPMC8763055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.